The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company’s global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ — Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation […]